Mometasone Arrow (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Arrow, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis and nasal polyps in adults and children, reducing congestion, sneezing and nasal discharge by targeting inflammation within the nasal mucosa. The formulation is designed for topical application inside the nasal passages, providing localized anti‑inflammatory action with minimal systemic exposure.

GNH USA supplies Mometasone Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone Arrow, a nasal corticosteroid, is used to manage inflammatory conditions of the nasal passages.

Allergic rhinitis: alleviates nasal congestion, sneezing, itching and rhinorrhea. Nasal polyps: reduces polyp size and improves nasal airflow. Chronic rhinosinusitis with nasal polyps: decreases inflammation and supports sinus drainage.

Mometasone Arrow may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning - Headache - Epistaxis (nosebleeds) - Throat dryness

Serious or Rare Side Effects: - Fungal infection of nasal mucosa - Adrenal suppression with prolonged use - Allergic reactions including anaphylaxis

Before prescribing Mometasone Arrow, consider the following precautions to ensure safe use.

- Assess for active nasal infection: avoid use if bacterial or fungal infection present. - Monitor for signs of adrenal suppression: especially with long‑term or high‑dose therapy. - Avoid in children under 2 years: safety and efficacy not established. - Use the lowest effective dose: to minimize systemic exposure. - Store at room temperature: keep in original container, protect from moisture and heat.

Mometasone Arrow can interact with other medicines that affect corticosteroid activity or metabolism.

Major Interactions (Avoid): - Concurrent systemic corticosteroids: may increase overall glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local drug exposure. - Live vaccines: nasal steroid may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Moderate CYP3A4 inhibitors (e.g., erythromycin): may modestly increase exposure. - Antifungal azoles: may increase local concentrations. - Nasal decongestants: may cause additive nasal irritation.